secwatch.observer — SEC 8-K summary
======================================

Issuer:     Day One Biopharmaceuticals, Inc. (—)
CIK:        0001845337
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001193125-23-277887
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Day One Biopharma dismisses EY as auditor, appoints PwC effective Nov 10, 2023
------------------------------------------------------------------------------

- Audit Committee dismissed EY on Nov 10, 2023; no disagreements or reportable events in prior periods.
- PwC appointed as independent registered public accounting firm for fiscal year ending Dec 31, 2023.
- EY's reports for FY2021 and FY2022 were unqualified and contained no adverse opinions.
- Neither the company nor anyone on its behalf consulted PwC on accounting matters before engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523277887/0001193125-23-277887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523277887/d361807d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer